On Monday, Capricor Therapeutics Inc (NASDAQ: CAPR) was 52.86% up from the session before settling in for the closing price of $9.95. A 52-week range for CAPR has been $2.68 – $12.87.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 339.72% over the past five years. When this article was written, the company’s average yearly earnings per share was at -47.71%. With a float of $27.08 million, this company’s outstanding shares have now reached $31.15 million.
Let’s look at the performance matrix of the company that is accounted for 102 employees.
Capricor Therapeutics Inc (CAPR) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Capricor Therapeutics Inc stocks. The insider ownership of Capricor Therapeutics Inc is 16.78%, while institutional ownership is 19.89%. The most recent insider transaction that took place on Sep 20 ’24, was worth 14,999,998. In this transaction 10% Owner of this company bought 2,798,507 shares at a rate of $5.36, taking the stock ownership to the 7,090,351 shares. Before that another transaction happened on Oct 12 ’23, when Company’s Director bought 410 for $2.75, making the entire transaction worth $1,128. This insider now owns 31,536 shares in total.
Capricor Therapeutics Inc (CAPR) Performance Highlights and Predictions
#####
According to the Wall Street analysts, stocks earnings will be around -47.71% per share during the next fiscal year.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
You can see what Capricor Therapeutics Inc (CAPR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Capricor Therapeutics Inc (NASDAQ: CAPR) saw its 5-day average volume 19.24 million, a positive change from its year-to-date volume of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 75.61%. Additionally, its Average True Range was 1.23.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 96.37%, which indicates a significant increase from 96.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 233.12% in the past 14 days, which was higher than the 116.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.01, while its 200-day Moving Average is $5.08. Nevertheless, the first resistance level for the watch stands at $17.28 in the near term. At $19.36, the stock is likely to face the second major resistance level. The third major resistance level sits at $23.06. If the price goes on to break the first support level at $11.50, it is likely to go to the next support level at $7.80. Assuming the price breaks the second support level, the third support level stands at $5.72.
Capricor Therapeutics Inc (NASDAQ: CAPR) Key Stats
There are 31,979K outstanding shares of the company, which has a market capitalization of 494.93 million. As of now, sales total 25,180 K while income totals -22,290 K. Its latest quarter income was 3,970 K while its last quarter net income were -11,000 K.
